SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SLV-154 enters human testing for multiple advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-154 in about 70 people whose solid tumors (like head and neck, lung, breast, or ovarian cancer) have spread. The main goal is to find a safe dose and watch for side effects. Participants must have a confirmed diagnosis and be in …
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New trial aims to improve survival in head and neck cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether adding chemotherapy to standard radiation therapy after surgery helps people with intermediate-risk head and neck squamous cell carcinoma live longer without the cancer returning. About 386 adults who have had surgery and show certain risk factors…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
Sound waves zapped into brain to kill cancer pain
Symptom relief Recruiting nowThis early-stage study tests whether a precise ultrasound beam can be used to create a tiny lesion in the brain's pain center to relieve severe, opioid-resistant pain in people with head, neck, or brachial cancer. About 20 adults aged 18-85 will take part. The goal is to check sa…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC
-
New radiation technique aims to save cancer Patients' saliva
Symptom relief Recruiting nowThis study tests a new daily adaptive radiotherapy (ART) approach for head and neck cancer patients to see if it can better protect the submandibular glands, which produce saliva. About 50 participants will receive either standard radiation or the new ART method. The goal is to r…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 05, 2026 11:54 UTC